CTI BIOPHARMA CORP's ticker is CTICXXXX and the CUSIP is 12648L106. A total of 97 filers reported holding CTI BIOPHARMA CORP in Q1 2015. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $38,000 | – | 16,212 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DAFNA Capital Management LLC | 1,425,000 | $3,363,000 | 2.66% |
ACUTA CAPITAL PARTNERS, LLC | 1,228,111 | $2,898,000 | 1.96% |
Sio Capital Management, LLC | 505,000 | $1,192,000 | 0.94% |
RA Capital Management | 2,500,000 | $5,900,000 | 0.63% |
SPHERA FUNDS MANAGEMENT LTD. | 750,000 | $1,770,000 | 0.30% |
TFS CAPITAL LLC | 1,295,744 | $3,058,000 | 0.29% |
EAGLE ASSET MANAGEMENT INC | 12,713,051 | $30,002,000 | 0.17% |
JW Asset Management, LLC | 52,271 | $123,000 | 0.09% |
Lombard Odier Asset Management (USA) Corp | 501,444 | $1,183,000 | 0.08% |
First Heartland Consultants, Inc. | 74,624 | $176,000 | 0.07% |